Skip to Content

Ginkgo Bioworks Holdings, Inc.

Company NameGinkgo Bioworks Holdings, Inc.
Stock SymbolDNA
Class PeriodMay 11, 2021 to October 05, 2021
Lead Plaintiff Motion DeadlineJanuary 18, 2022

On October 6, 2021, Scorpion Capital published a 175-page research report alleging that Ginkgo Bioworks is a "colossal scam" and that its business model is a "shell game." According to the report, Ginkgo Bioworks is highly dependent on related party transaction revenues and the Company is a "Frankenstein mash-up of the worst frauds of the last 20 years."

On this news, the Company’s share price fell as much as 17% during intraday trading on October 6, 2021, thereby injuring investors.


Submit Your Information

If you suffered a loss on your Ginkgo Bioworks Holdings, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Shares Purchased

Number of SharesBuy DatePrice Per ShareAdd

Shares Sold

Number of SharesSell DatePrice Per ShareAdd